0001485003-16-000120.txt : 20160629
0001485003-16-000120.hdr.sgml : 20160629
20160629161421
ACCESSION NUMBER: 0001485003-16-000120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160627
FILED AS OF DATE: 20160629
DATE AS OF CHANGE: 20160629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Celniker Abbie
CENTRAL INDEX KEY: 0001590250
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 161738969
MAIL ADDRESS:
STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC.
STREET 2: 215 FIRST STREET, SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wf-form4_146723124831863.xml
FORM 4
X0306
4
2016-06-27
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001590250
Celniker Abbie
C/O ELEVEN BIOTHERAPEUTICS, INC.,
215 FIRST STREET, SUITE 400
CAMBRIDGE
MA
02142
1
1
0
0
President and CEO
Common Stock
2016-06-27
4
S
0
10029
2.08
D
419946
D
The shares of common stock underlying the restricted stock units reported as disposed herein were sold by the issuer in satisfaction of tax withholding obligations associated with the vesting of such units.
/s/ John J. McCabe as attorney-in-fact
2016-06-29